
Keywords: endoglin; CD105 TGF-β; BMP9; ALK-1; TRC105; tumor microenvironment
Activin Receptors, Type II, Review, TRC105, Adaptive Immunity, BMP9, Ligands, Microbiology, Mice, Neoplasms, Growth Differentiation Factor 2, tumor microenvironment, Animals, Humans, Endothelium, Phosphorylation, ALK-1, endoglin, Clinical Trials as Topic, Neovascularization, Pathologic, Endoglin, Antibodies, Monoclonal, Epithelial Cells, Mesenchymal Stem Cells, Fibrosis, QR1-502, Immunity, Innate, Hematopoiesis, n/a, CD105 TGF-beta, Signal Transduction
Activin Receptors, Type II, Review, TRC105, Adaptive Immunity, BMP9, Ligands, Microbiology, Mice, Neoplasms, Growth Differentiation Factor 2, tumor microenvironment, Animals, Humans, Endothelium, Phosphorylation, ALK-1, endoglin, Clinical Trials as Topic, Neovascularization, Pathologic, Endoglin, Antibodies, Monoclonal, Epithelial Cells, Mesenchymal Stem Cells, Fibrosis, QR1-502, Immunity, Innate, Hematopoiesis, n/a, CD105 TGF-beta, Signal Transduction
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 88 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 1% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |
